JP2011508592A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011508592A5 JP2011508592A5 JP2010538920A JP2010538920A JP2011508592A5 JP 2011508592 A5 JP2011508592 A5 JP 2011508592A5 JP 2010538920 A JP2010538920 A JP 2010538920A JP 2010538920 A JP2010538920 A JP 2010538920A JP 2011508592 A5 JP2011508592 A5 JP 2011508592A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- binding member
- isolated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 21
- 101001002709 Homo sapiens Interleukin-4 Proteins 0.000 claims 3
- 101001033312 Homo sapiens Interleukin-4 receptor subunit alpha Proteins 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 102000055229 human IL4 Human genes 0.000 claims 3
- 102000054663 human IL4R Human genes 0.000 claims 3
- 238000006467 substitution reaction Methods 0.000 claims 3
- 206010020751 Hypersensitivity Diseases 0.000 claims 2
- 208000026935 allergic disease Diseases 0.000 claims 2
- 230000007815 allergy Effects 0.000 claims 2
- 210000004602 germ cell Anatomy 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 claims 1
- 102000009109 Fc receptors Human genes 0.000 claims 1
- 108010087819 Fc receptors Proteins 0.000 claims 1
- 102100026120 IgG receptor FcRn large subunit p51 Human genes 0.000 claims 1
- 101710177940 IgG receptor FcRn large subunit p51 Proteins 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 102000010787 Interleukin-4 Receptors Human genes 0.000 claims 1
- 101001002707 Macaca fascicularis Interleukin-4 Proteins 0.000 claims 1
- 206010052779 Transplant rejections Diseases 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 206010006451 bronchitis Diseases 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 230000004663 cell proliferation Effects 0.000 claims 1
- 238000001516 cell proliferation assay Methods 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 208000010247 contact dermatitis Diseases 0.000 claims 1
- 230000003176 fibrotic effect Effects 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1586907P | 2007-12-21 | 2007-12-21 | |
| US61/015,869 | 2007-12-21 | ||
| PCT/GB2008/051212 WO2009081201A2 (en) | 2007-12-21 | 2008-12-19 | BINDING MEMBERS FOR INTERLEUKIN-4 RECEPTOR ALPHA (IL-4Rα) - 173 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014130983A Division JP6093734B2 (ja) | 2007-12-21 | 2014-06-26 | インターロイキン−４受容体α（ＩＬ−４Ｒα）−１７３に対する結合メンバー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011508592A JP2011508592A (ja) | 2011-03-17 |
| JP2011508592A5 true JP2011508592A5 (enExample) | 2012-02-09 |
| JP5571567B2 JP5571567B2 (ja) | 2014-08-13 |
Family
ID=40532664
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010538920A Expired - Fee Related JP5571567B2 (ja) | 2007-12-21 | 2008-12-19 | インターロイキン−４受容体α（ＩＬ−４Ｒα）−１７３に対する結合メンバー |
| JP2014130983A Expired - Fee Related JP6093734B2 (ja) | 2007-12-21 | 2014-06-26 | インターロイキン−４受容体α（ＩＬ−４Ｒα）−１７３に対する結合メンバー |
| JP2016244210A Pending JP2017095467A (ja) | 2007-12-21 | 2016-12-16 | インターロイキン−４受容体α（ＩＬ−４Ｒα）−１７３に対する結合メンバー |
| JP2018107457A Pending JP2018148922A (ja) | 2007-12-21 | 2018-06-05 | インターロイキン−４受容体α（ＩＬ−４Ｒα）−１７３に対する結合メンバー |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014130983A Expired - Fee Related JP6093734B2 (ja) | 2007-12-21 | 2014-06-26 | インターロイキン−４受容体α（ＩＬ−４Ｒα）−１７３に対する結合メンバー |
| JP2016244210A Pending JP2017095467A (ja) | 2007-12-21 | 2016-12-16 | インターロイキン−４受容体α（ＩＬ−４Ｒα）−１７３に対する結合メンバー |
| JP2018107457A Pending JP2018148922A (ja) | 2007-12-21 | 2018-06-05 | インターロイキン−４受容体α（ＩＬ−４Ｒα）−１７３に対する結合メンバー |
Country Status (14)
| Country | Link |
|---|---|
| EP (3) | EP3211010A1 (enExample) |
| JP (4) | JP5571567B2 (enExample) |
| KR (2) | KR101759457B1 (enExample) |
| CN (2) | CN104788563A (enExample) |
| AU (2) | AU2008339576B2 (enExample) |
| BR (1) | BRPI0822099A2 (enExample) |
| CA (1) | CA2708871C (enExample) |
| DK (1) | DK2245064T3 (enExample) |
| ES (1) | ES2518415T3 (enExample) |
| HK (1) | HK1212364A1 (enExample) |
| MX (2) | MX343594B (enExample) |
| PL (1) | PL2245064T3 (enExample) |
| RU (2) | RU2490278C2 (enExample) |
| WO (1) | WO2009081201A2 (enExample) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7608693B2 (en) | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| US8092804B2 (en) | 2007-12-21 | 2012-01-10 | Medimmune Limited | Binding members for interleukin-4 receptor alpha (IL-4Rα)-173 |
| KR101722961B1 (ko) | 2009-02-11 | 2017-04-04 | 알부메딕스 에이/에스 | 알부민 변이체 및 접합체 |
| MX2012004793A (es) | 2009-10-30 | 2012-07-20 | Novozymes Biopharma Dk As | Variantes de albumina. |
| JP5969458B2 (ja) * | 2010-04-09 | 2016-08-17 | アルブミディクス アクティーゼルスカブ | アルブミン誘導体及び変異体 |
| US9255144B2 (en) * | 2010-12-20 | 2016-02-09 | Medimmune Limited | Anti-IL-18 antibodies and their uses |
| EP2535714A1 (en) * | 2011-06-16 | 2012-12-19 | Istituto Nazionale Di Genetica Molecolare-INGM | Biomarkers for autoimmune liver diseases and uses thereof |
| WO2013055404A1 (en) * | 2011-10-10 | 2013-04-18 | City Of Hope | Meditopes and meditope-binding antibodies and uses thereof |
| US20140315817A1 (en) | 2011-11-18 | 2014-10-23 | Eleven Biotherapeutics, Inc. | Variant serum albumin with improved half-life and other properties |
| EP2596802A1 (en) | 2011-11-23 | 2013-05-29 | PLS-Design GmbH | Pharmaceutical composition for treatment of allergic reactions |
| DK2825556T3 (en) | 2012-03-16 | 2018-04-16 | Albumedix As | albumin Variants |
| EP2674168A1 (en) | 2012-06-14 | 2013-12-18 | PLS-Design GmbH | Modulation of effector T cell responses by local depletion of complement component C3 |
| HUE064945T2 (hu) | 2012-08-21 | 2024-04-28 | Sanofi Biotechnology | Eljárások asztma kezelésére vagy megelõzésére IL-4R antagonista beadásával |
| KR20150082422A (ko) | 2012-11-08 | 2015-07-15 | 노보자임스 바이오파마 디케이 에이/에스 | 알부민 변이체 |
| KR20160024916A (ko) * | 2013-06-21 | 2016-03-07 | 사노피 바이오테크놀로지 | Il-4r 길항제를 투여함에 의한 비용종증의 치료 방법 |
| DE202014010499U1 (de) | 2013-12-17 | 2015-10-20 | Kymab Limited | Targeting von humaner PCSK9 zur Cholesterinbehandlung |
| US8986691B1 (en) | 2014-07-15 | 2015-03-24 | Kymab Limited | Method of treating atopic dermatitis or asthma using antibody to IL4RA |
| US8980273B1 (en) | 2014-07-15 | 2015-03-17 | Kymab Limited | Method of treating atopic dermatitis or asthma using antibody to IL4RA |
| IL315136A (en) * | 2014-02-21 | 2024-10-01 | Sanofi Biotechnology | Methods for treating or preventing asthma by administering an il-4rantagonist |
| NZ726520A (en) | 2014-05-29 | 2018-12-21 | Macrogenics Inc | Tri-specific binding molecules that specifically bind to multiple cancer antigens and methods of use thereof |
| WO2016023916A1 (en) | 2014-08-12 | 2016-02-18 | Kymab Limited | Treatment of disease using ligand binding to targets of interest |
| AU2015310879A1 (en) * | 2014-09-03 | 2017-03-02 | Medimmune Limited | Stable anti-IL-4R-alpha antibody formulation |
| WO2016036918A1 (en) * | 2014-09-03 | 2016-03-10 | Boehringer Ingelheim International Gmbh | Compound targeting il-23a and tnf-alpha and uses thereof |
| WO2016071701A1 (en) | 2014-11-07 | 2016-05-12 | Kymab Limited | Treatment of disease using ligand binding to targets of interest |
| EP3218412A1 (en) * | 2014-11-14 | 2017-09-20 | Sanofi Biotechnology | Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist |
| WO2016156588A1 (en) * | 2015-04-02 | 2016-10-06 | Intervet International B.V. | Antibodies to canine interleukin-4 receptor alpha |
| KR102644875B1 (ko) | 2015-07-23 | 2024-03-06 | 베링거잉겔하임인터내쇼날유한회사 | Il-23a 및 b-세포 활성화 인자(baff)를 표적화하는 화합물 및 이의 용도 |
| EP3337816B1 (en) | 2015-08-20 | 2024-02-14 | Albumedix Ltd | Albumin variants and conjugates |
| RU2753869C2 (ru) | 2016-02-19 | 2021-08-24 | Ридженерон Фармасьютикалз, Инк. | Способы повышения эффективности вакцины путем введения антагониста il-4r |
| EP3433615A1 (en) | 2016-03-21 | 2019-01-30 | Institut National de la Sante et de la Recherche Medicale (INSERM) | Methods for diagnosis and treatment of solar lentigo |
| CN105753987A (zh) * | 2016-05-11 | 2016-07-13 | 贵阳中医学院 | 抗il-4r单链抗体的制备方法及其在抗肿瘤上的应用 |
| GB201610198D0 (en) | 2016-06-10 | 2016-07-27 | Ucb Biopharma Sprl | Anti-ige antibodies |
| EA037848B1 (ru) | 2016-07-14 | 2021-05-27 | Общество С Ограниченной Ответственностью "Биохимический Агент" | Гибридный белок, полинуклеотид, генетическая конструкция, продуцент, препарат для регенерации хряща (варианты) |
| HUE064655T2 (hu) | 2017-10-30 | 2024-04-28 | Sanofi Biotechnology | IL-4R antagonista asztma kezelésére vagy megelõzésére szolgáló eljárásban |
| RU2758092C1 (ru) * | 2018-02-01 | 2021-10-26 | Бэйцзин Кавин Текнолоджи Шеа-Холдинг Ко., Лтд. | АНТИТЕЛО К IL-4Rα И ЕГО ПРИМЕНЕНИЕ |
| CA3105527A1 (en) * | 2018-08-24 | 2020-02-27 | Jiangsu Hengrui Medicine Co., Ltd. | Human il-4r binding antibody, antigen binding fragment thereof, and medical use thereof |
| CN109459372B (zh) * | 2018-10-29 | 2021-03-26 | 迪瑞医疗科技股份有限公司 | 有核红细胞模拟粒子及其制备方法与应用 |
| KR102330596B1 (ko) | 2018-11-09 | 2021-11-26 | 아주대학교산학협력단 | 인간 il-4 수용체 알파에 대한 고친화도 인간 항체 및 이의 용도 |
| CN111518211B (zh) * | 2018-12-25 | 2022-06-21 | 江苏荃信生物医药股份有限公司 | 抗人白介素4受体α单克隆抗体的制药用途 |
| SG11202107007VA (en) * | 2018-12-27 | 2021-07-29 | Akeso Biopharma Inc | Antibody against human il-4ra and use thereof |
| CN111592597B (zh) * | 2019-05-29 | 2022-04-26 | 山东博安生物技术股份有限公司 | 白介素4受体(il-4r)结合蛋白及其用途 |
| MX2022000649A (es) | 2019-07-16 | 2022-06-08 | Sanofi Biotechnology | Metodos para tratar o prevenir el asma mediante la administracion de un antagonista de il-4r. |
| CN113527485B (zh) * | 2020-04-17 | 2024-11-15 | 湖南麦济生物技术股份有限公司 | 抗人白细胞介素-4受体α抗体及其制备方法和应用 |
| CN113549151A (zh) * | 2020-04-24 | 2021-10-26 | 苏州康乃德生物医药有限公司 | 与人IL-4Rα中特定表位结合的抗体及其应用 |
| TW202216782A (zh) * | 2020-09-10 | 2022-05-01 | 大陸商舒泰神（北京）生物製藥股份有限公司 | 特異性識別白細胞介素—４受體α的抗體及其用途 |
| CN114605539B (zh) * | 2020-12-09 | 2024-01-02 | 南京融捷康生物科技有限公司 | 人源化的抗IL-4Rα单域抗体及其应用 |
| TWI876192B (zh) * | 2021-08-05 | 2025-03-11 | 美商美國禮來大藥廠 | 人類介白素-4受體α抗體 |
Family Cites Families (100)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4318980A (en) | 1978-04-10 | 1982-03-09 | Miles Laboratories, Inc. | Heterogenous specific binding assay employing a cycling reactant as label |
| US4424200A (en) | 1979-05-14 | 1984-01-03 | Nuc Med Inc. | Method for radiolabeling proteins with technetium-99m |
| US4479930A (en) | 1982-07-26 | 1984-10-30 | Trustees Of The University Of Massachusetts | Amines coupled wth dicyclic dianhydrides capable of being radiolabeled product |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| AU600575B2 (en) | 1987-03-18 | 1990-08-16 | Sb2, Inc. | Altered antibodies |
| US5677425A (en) | 1987-09-04 | 1997-10-14 | Celltech Therapeutics Limited | Recombinant antibody |
| US5185243A (en) | 1988-08-25 | 1993-02-09 | Syntex (U.S.A.) Inc. | Method for detection of specific nucleic acid sequences |
| WO1990005183A1 (en) * | 1988-10-31 | 1990-05-17 | Immunex Corporation | Interleukin-4 receptors |
| FR2650598B1 (fr) | 1989-08-03 | 1994-06-03 | Rhone Poulenc Sante | Derives de l'albumine a fonction therapeutique |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US6172197B1 (en) | 1991-07-10 | 2001-01-09 | Medical Research Council | Methods for producing members of specific binding pairs |
| GB9206318D0 (en) | 1992-03-24 | 1992-05-06 | Cambridge Antibody Tech | Binding substances |
| US6492160B1 (en) | 1991-05-15 | 2002-12-10 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| US5858657A (en) | 1992-05-15 | 1999-01-12 | Medical Research Council | Methods for producing members of specific binding pairs |
| DE69230142T2 (de) | 1991-05-15 | 2000-03-09 | Cambridge Antibody Technology Ltd. | Verfahren zur herstellung von spezifischen bindungspaargliedern |
| US6225447B1 (en) | 1991-05-15 | 2001-05-01 | Cambridge Antibody Technology Ltd. | Methods for producing members of specific binding pairs |
| US5962255A (en) | 1992-03-24 | 1999-10-05 | Cambridge Antibody Technology Limited | Methods for producing recombinant vectors |
| EP0590058B1 (en) | 1991-06-14 | 2003-11-26 | Genentech, Inc. | HUMANIZED Heregulin ANTIBODy |
| US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
| ATE408012T1 (de) | 1991-12-02 | 2008-09-15 | Medical Res Council | Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken |
| US5872215A (en) | 1991-12-02 | 1999-02-16 | Medical Research Council | Specific binding members, materials and methods |
| FR2686901A1 (fr) | 1992-01-31 | 1993-08-06 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides antithrombotiques, leur preparation et compositions pharmaceutiques les contenant. |
| FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
| GB9203459D0 (en) * | 1992-02-19 | 1992-04-08 | Scotgen Ltd | Antibodies with germ-line variable regions |
| US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| CA2118508A1 (en) | 1992-04-24 | 1993-11-11 | Elizabeth S. Ward | Recombinant production of immunoglobulin-like domains in prokaryotic cells |
| EP0672142B1 (en) | 1992-12-04 | 2001-02-28 | Medical Research Council | Multivalent and multispecific binding proteins, their manufacture and use |
| US5885573A (en) | 1993-06-01 | 1999-03-23 | Arch Development Corporation | Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies |
| WO1994029351A2 (en) | 1993-06-16 | 1994-12-22 | Celltech Limited | Antibodies |
| RU2162711C2 (ru) * | 1993-09-07 | 2001-02-10 | Смитклайн Бичам Корпорейшн | Рекомбинантные il4-антитела, используемые для лечения нарушений, связанных с действием il4 |
| JP3773556B2 (ja) * | 1993-09-08 | 2006-05-10 | 味の素株式会社 | 抗アレルギー剤 |
| US6121022A (en) | 1995-04-14 | 2000-09-19 | Genentech, Inc. | Altered polypeptides with increased half-life |
| US5869046A (en) | 1995-04-14 | 1999-02-09 | Genentech, Inc. | Altered polypeptides with increased half-life |
| US6410690B1 (en) | 1995-06-07 | 2002-06-25 | Medarex, Inc. | Therapeutic compounds comprised of anti-Fc receptor antibodies |
| TW311927B (enExample) | 1995-07-11 | 1997-08-01 | Minnesota Mining & Mfg | |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| WO1997030035A1 (en) | 1996-02-13 | 1997-08-21 | Zeneca Limited | Quinazoline derivatives as vegf inhibitors |
| PT885198E (pt) | 1996-03-05 | 2002-06-28 | Astrazeneca Ab | Derivados de 4-anilinoquinazolina |
| WO1997034361A1 (de) | 1996-03-14 | 1997-09-18 | Gutt Hans Joachim | Mehrfachnutzung von hochtemperatur-supraleitern in elektrischen maschinen |
| US5814468A (en) | 1996-03-27 | 1998-09-29 | Coulter International Corp. | Methods of enumerating receptor molecules for specific binding partners on formed bodies and in solution |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| WO1998023289A1 (en) | 1996-11-27 | 1998-06-04 | The General Hospital Corporation | MODULATION OF IgG BINDING TO FcRn |
| US6277375B1 (en) | 1997-03-03 | 2001-08-21 | Board Of Regents, The University Of Texas System | Immunoglobulin-like domains with increased half-lives |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| US6194551B1 (en) | 1998-04-02 | 2001-02-27 | Genentech, Inc. | Polypeptide variants |
| DE69937291T2 (de) | 1998-04-02 | 2008-07-10 | Genentech, Inc., South San Francisco | Antikörpervarianten und fragmente davon |
| US6528624B1 (en) | 1998-04-02 | 2003-03-04 | Genentech, Inc. | Polypeptide variants |
| JP4334141B2 (ja) | 1998-04-20 | 2009-09-30 | グリカート バイオテクノロジー アクチェンゲゼルシャフト | 抗体依存性細胞傷害性を改善するための抗体のグリコシル化操作 |
| GB9809951D0 (en) | 1998-05-08 | 1998-07-08 | Univ Cambridge Tech | Binding molecules |
| JPH11332567A (ja) * | 1998-05-22 | 1999-12-07 | Dai Ichi Seiyaku Co Ltd | アトピー体質の判定方法 |
| PT1137941E (pt) | 1998-12-10 | 2009-10-15 | Brystol Myers Squibb Company | Esqueletos de proteínas para compostos miméticos de anticorpos e outras proteínas de ligação |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| US6737056B1 (en) | 1999-01-15 | 2004-05-18 | Genentech, Inc. | Polypeptide variants with altered effector function |
| BR0008758A (pt) | 1999-01-15 | 2001-12-04 | Genentech Inc | Variantes de polipeptìdeos parentais com funçãoefetora alterada, polipeptìdeos, composição ácidonucleico isolado, vetor, célula hospedeira,método para produzir uma variante depolipeptìdeo, método para o tratamento de umadesordem em mamìferos e método para produziruma região fc variante |
| CA2369292C (en) | 1999-04-09 | 2010-09-21 | Kyowa Hakko Kogyo Co. Ltd. | Method of modulating the activity of functional immune molecules |
| WO2001029246A1 (fr) | 1999-10-19 | 2001-04-26 | Kyowa Hakko Kogyo Co., Ltd. | Procede de production d'un polypeptide |
| WO2001029224A2 (en) | 1999-10-20 | 2001-04-26 | Zymogenetics, Inc. | Granulocyte peptide homolog zgpa1 |
| ATE336514T1 (de) | 2000-02-11 | 2006-09-15 | Merck Patent Gmbh | Steigerung der zirkulierenden halbwertzeit von auf antikörpern basierenden fusionsproteinen |
| CA2405550A1 (en) | 2000-04-12 | 2001-10-25 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| AU5345901A (en) | 2000-04-13 | 2001-10-30 | Univ Rockefeller | Enhancement of antibody-mediated immune responses |
| EP2990420B1 (en) * | 2000-05-26 | 2016-12-21 | Immunex Corporation | Use of interleukin-4 receptor antibodies and compositions thereof |
| US20020002132A1 (en) * | 2000-05-26 | 2002-01-03 | Pluenneke John D. | Use of interleukin-4 antagonists and compositions thereof |
| AU2001258628A1 (en) | 2000-05-31 | 2001-12-11 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
| BR0112225A (pt) | 2000-07-07 | 2003-05-06 | Angiogene Pharm Ltd | Composto, composição farmacêutica, uso de um composto, e, processo papa preparar um composto |
| MXPA02012905A (es) | 2000-07-07 | 2004-07-30 | Angiogene Pharm Ltd | Derivados de colquinol como agentes de dano vascular.. |
| US6725230B2 (en) | 2000-07-18 | 2004-04-20 | Aegis Analytical Corporation | System, method and computer program for assembling process data of multi-database origins using a hierarchical display |
| US6946292B2 (en) | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| AU2001294175A1 (en) | 2000-10-06 | 2002-04-22 | Kyowa Hakko Kogyo Co. Ltd. | Method of purifying antibody |
| EA013563B1 (ru) | 2000-10-06 | 2010-06-30 | Киова Хакко Кирин Ко., Лтд. | Трансгенное животное, продуцирующее антитела с измененными углеводными цепями, способ получения антител и содержащее антитела лекарственное средство |
| PT1355919E (pt) | 2000-12-12 | 2011-03-02 | Medimmune Llc | Moléculas com semivida longa, composições que as contêm e suas utilizações |
| JP2005500018A (ja) | 2001-04-02 | 2005-01-06 | アイデック ファーマスーティカルズ コーポレイション | ＧｎＴＩＩＩと同時発現する組換え抗体 |
| ATE430580T1 (de) | 2001-10-25 | 2009-05-15 | Genentech Inc | Glycoprotein-zusammensetzungen |
| ES2384100T3 (es) * | 2001-12-03 | 2012-06-29 | Alexion Pharmaceuticals, Inc. | Método para producir anticuerpos híbridos |
| US20040002587A1 (en) | 2002-02-20 | 2004-01-01 | Watkins Jeffry D. | Fc region variants |
| US20040132101A1 (en) | 2002-09-27 | 2004-07-08 | Xencor | Optimized Fc variants and methods for their generation |
| JP4459810B2 (ja) | 2002-08-14 | 2010-04-28 | マクロジェニクス，インコーポレーテッド | ＦｃγＲＩＩＢ特異的抗体とその利用法 |
| CA2499816C (en) | 2002-09-27 | 2013-07-30 | Xencor, Inc. | Optimized fc variants and methods for their generation |
| AU2003286467B2 (en) | 2002-10-15 | 2009-10-01 | Abbvie Biotherapeutics Inc. | Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis |
| EP1587540B1 (en) | 2003-01-09 | 2021-09-15 | MacroGenics, Inc. | IDENTIFICATION AND ENGINEERING OF ANTIBODIES WITH VARIANT Fc REGIONS AND METHODS OF USING SAME |
| DK1639011T3 (da) * | 2003-06-30 | 2009-02-16 | Domantis Ltd | Pegylerede enkelt-domæne antistoffer (dAb) |
| GB0324368D0 (en) | 2003-10-17 | 2003-11-19 | Univ Cambridge Tech | Polypeptides including modified constant regions |
| WO2005047331A2 (en) * | 2003-11-07 | 2005-05-26 | Immunex Corporation | Antibodies that bind interleukin-4 receptor |
| CA2552788C (en) | 2004-01-12 | 2013-09-24 | Applied Molecular Evolution, Inc. | Fc region variants |
| EP2053062A1 (en) | 2004-03-24 | 2009-04-29 | Xencor, Inc. | Immunoglobin variants outside the Fc region |
| US7618817B2 (en) | 2004-07-10 | 2009-11-17 | Fox Chase Cancer Center | Genetically modified human natural killer cell lines |
| BRPI0514068B8 (pt) | 2004-08-04 | 2021-05-25 | Applied Molecular Evolution Inc | anticorpo anti-cd20, e, composição farmacêutica |
| AU2005277567A1 (en) | 2004-08-16 | 2006-03-02 | Medimmune, Llc | Integrin antagonists with enhanced antibody dependent cell-mediated cytotoxicity activity |
| AU2006204396B2 (en) | 2005-01-10 | 2011-08-11 | Medimmune Limited | Method of mutagenesis |
| EA201100642A1 (ru) * | 2005-04-25 | 2011-12-30 | Пфайзер Инк. | Антитела к миостатину |
| MX2008008968A (es) | 2006-01-11 | 2008-09-10 | Aerovance Inc | Metodos y composiciones para tratar asma en primates humanos y no humanos. |
| PE20080333A1 (es) * | 2006-06-08 | 2008-06-15 | Chugai Pharmaceutical Co Ltd | Agentes para prevenir o tratar enfermedades inflamatorias |
| WO2008054606A2 (en) | 2006-10-02 | 2008-05-08 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human il-4 receptor |
| US9209965B2 (en) | 2014-01-14 | 2015-12-08 | Microsemi Semiconductor Ulc | Network interface with clock recovery module on line card |
| US11392902B2 (en) | 2017-06-06 | 2022-07-19 | United Parcel Service Of America, Inc. | Systems, methods, apparatuses and computer program products for providing notification of items for pickup and delivery |
-
2008
- 2008-12-19 EP EP16204833.4A patent/EP3211010A1/en not_active Withdrawn
- 2008-12-19 ES ES08865613.7T patent/ES2518415T3/es active Active
- 2008-12-19 KR KR1020167011877A patent/KR101759457B1/ko not_active Expired - Fee Related
- 2008-12-19 BR BRPI0822099A patent/BRPI0822099A2/pt active Search and Examination
- 2008-12-19 CN CN201410733833.9A patent/CN104788563A/zh active Pending
- 2008-12-19 JP JP2010538920A patent/JP5571567B2/ja not_active Expired - Fee Related
- 2008-12-19 PL PL08865613T patent/PL2245064T3/pl unknown
- 2008-12-19 CA CA2708871A patent/CA2708871C/en not_active Expired - Fee Related
- 2008-12-19 EP EP08865613.7A patent/EP2245064B1/en not_active Not-in-force
- 2008-12-19 RU RU2010129558/10A patent/RU2490278C2/ru not_active IP Right Cessation
- 2008-12-19 CN CN200880123045.0A patent/CN102046658B/zh not_active Expired - Fee Related
- 2008-12-19 MX MX2013005138A patent/MX343594B/es unknown
- 2008-12-19 DK DK08865613.7T patent/DK2245064T3/da active
- 2008-12-19 MX MX2010006735A patent/MX2010006735A/es active IP Right Grant
- 2008-12-19 WO PCT/GB2008/051212 patent/WO2009081201A2/en not_active Ceased
- 2008-12-19 EP EP13152097.5A patent/EP2604628A3/en not_active Withdrawn
- 2008-12-19 AU AU2008339576A patent/AU2008339576B2/en not_active Ceased
- 2008-12-19 KR KR1020107016269A patent/KR101620539B1/ko not_active Expired - Fee Related
-
2013
- 2013-05-24 RU RU2013123927/10A patent/RU2013123927A/ru not_active Application Discontinuation
-
2014
- 2014-06-16 AU AU2014203248A patent/AU2014203248B2/en not_active Ceased
- 2014-06-26 JP JP2014130983A patent/JP6093734B2/ja not_active Expired - Fee Related
-
2016
- 2016-01-12 HK HK16100316.9A patent/HK1212364A1/xx unknown
- 2016-12-16 JP JP2016244210A patent/JP2017095467A/ja active Pending
-
2018
- 2018-06-05 JP JP2018107457A patent/JP2018148922A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011508592A5 (enExample) | ||
| AU2022202503B2 (en) | Oncostatin M receptor antigen binding proteins | |
| CA2914170C (en) | Interleukin-13 binding proteins | |
| KR101820699B1 (ko) | 항-ｖｅｇｆ／ｄｌｌ4 이원 가변 도메인 면역글로불린 및 이의 용도 | |
| TWI449709B (zh) | 能結合胸腺基質淋巴細胞生成素之抗體及其製造方法與用途 | |
| CN111494626B (zh) | 用于治疗il-4和/或il-13介导的信号转导相关的疾病的药物组合物 | |
| TWI769537B (zh) | 標靶ｂｃｍａ的抗體、雙專一性抗體及其用途 | |
| RU2013123927A (ru) | ЭЛЕМЕНТ, СВЯЗЫВАЮЩИЙСЯ С α-РЕЦЕПТОРОМ ИНТЕРЛЕЙКИНА-4 (IL-4α)-173 | |
| JP5836130B2 (ja) | ヒトｉｌ−１３に結合特異性を有する抗体分子 | |
| RU2008137763A (ru) | Связующий элемент для рецептора gm-csf | |
| JP2009533020A5 (enExample) | ||
| JP2008527989A5 (enExample) | ||
| AU2017201306A1 (en) | Anti-human respiratory syncytial virus (RSV) antibodies and methods of use | |
| CN117567621A (zh) | 抗lag-3抗体及组合物 | |
| JP2014508511A5 (enExample) | ||
| JP2008521440A5 (enExample) | ||
| JP2014503209A5 (enExample) | ||
| RU2012130840A (ru) | Соединения | |
| EP1991583A1 (en) | Thymic stromal lymphopoietin (tslp) antibodies and uses thereof | |
| TW201010725A (en) | Anti-IL-12/IL-23 antibodies | |
| US20230220086A1 (en) | Anti-st2 antibody and application thereof | |
| CN108164600B (zh) | 一种抗gpc3抗体及其制备方法和用途 | |
| TW202210520A (zh) | 標靶ｒｏｒ１的抗體或其抗原結合片段及製備方法和應用 | |
| JP2011523849A5 (enExample) | ||
| IL310419A (en) | Human interleukin-4 receptor alpha antibodies |